Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R5QM
|
||||
Former ID |
DNC011851
|
||||
Drug Name |
1-Butyl-4-(2-methoxy-phenyl)-piperazine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [533873] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H24N2O
|
||||
Canonical SMILES |
CCCCN1CCN(CC1)C2=CC=CC=C2OC
|
||||
InChI |
1S/C15H24N2O/c1-3-4-9-16-10-12-17(13-11-16)14-7-5-6-8-15(14)18-2/h5-8H,3-4,9-13H2,1-2H3
|
||||
InChIKey |
DCFYVNHQUVKFKK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [533873] | |
5-hydroxytryptamine 1A receptor | Target Info | Inhibitor | [533873] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP722:Serotonin HTR1 Group and FOS Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.